APEXIAN PHARMACEUTICALS
Apex Therapeutics is an emerging clinical-stage biotechnology company founded on the scientific discoveries of Dr. Mark R. Kelley, whose groundbreaking work on APE1/Ref-1 redox protein signaling at the Indiana University School of Medicine has provided a unique insight into this novel biological target. It was founded in 2005 and headquartered in Indianapolis, Indiana.
APEXIAN PHARMACEUTICALS
Social Links:
Industry:
Biotechnology Health Care Pharmaceutical
Founded:
2005-01-01
Address:
Indianapolis, Indiana, United States
Country:
United States
Website Url:
http://www.apexianpharma.com
Total Employee:
1+
Status:
Active
Contact:
(317) 684-9106
Email Addresses:
[email protected]
Total Funding:
6.88 M USD
Technology used in webpage:
Euro U.S. Server Location CreativeWork Schema
Similar Organizations
Aeovian Pharmaceuticals
Aeovian Pharmaceuticals aims to discover, develop, and commercialize therapeutics for the treatment of rare and age-related diseases.
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
Pliant Therapeutics
Pliant Therapeutics focuses on discovering, developing, and commercializing breakthrough treatments for fibrotic diseases.
Recro Pharma
Recro Pharma is a pharmaceutical company developing non-opioid therapeutics for the treatment of pain.
Ultragenyx Pharmaceutical
Ultragenyx Pharmaceutical focuses on the development of various products for the treatment of rare and ultra-rare diseases.
Zogenix
Zogenix develops and commercializes products for the treatment of central nervous system disorders and pain.
Current Employees Featured
Founder
Investors List
IU Ventures
IU Ventures investment in Venture Round - Apexian Pharmaceuticals
Elevate Ventures
Elevate Ventures investment in Series A - Apexian Pharmaceuticals
BioCrossroads
BioCrossroads investment in Venture Round - Apexian Pharmaceuticals
IU Ventures
IU Ventures investment in Seed Round - Apexian Pharmaceuticals
Official Site Inspections
http://www.apexianpharma.com Semrush global rank: 9 M Semrush visits lastest month: 445
- Host name: cloudproxy10107.sucuri.net
- IP address: 192.124.249.107
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Apexian Pharmaceuticals"
Apexian Pharmaceuticals - Crunchbase Company Profile & Funding
Contact Email [email protected] Phone Number (317) 684-9106 Apex Therapeutics is an emerging clinical-stage biotechnology company founded on the scientific discoveries of Dr. …See details»
Apexian Pharmaceuticals Company Profile | Management and
Www.apexianpharma.com Apexian Pharmaceuticals Profile and History Apexian Pharmaceuticals is a patient-centered biotechnology company dedicated to developing novel compounds that …See details»
Apexian Pharmaceuticals Inc - Company Profile and News
Company profile page for Apexian Pharmaceuticals Inc including stock price, company news, executives, board members, and contact informationSee details»
APEXIAN PHARMACEUTICALS, INC. - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for APEXIAN PHARMACEUTICALS, INC. of Indianapolis, IN. Get the latest business insights from Dun & …See details»
Overview, News & Similar companies - ZoomInfo.com
Oct 28, 2019 Apexian Pharmaceuticals contact info: Phone number: (317) 684-9196 Website: www.apexianpharma.com What does Apexian Pharmaceuticals do? Apexian Pharmaceuticals …See details»
Apexian Pharmaceuticals - Products, Competitors, Financials, …
Headquarters Location. 20 N Meridian Street Suite 801. Indianapolis, Indiana, 46204, United States. 317-684-9196See details»
Apexian Pharmaceuticals - Craft
Apexian Pharmaceuticals is a biotechnology company that provides medicines for cancer. It focuses on inflammatory disorders and tumorigenesis, including cancers of the colon, …See details»
Apexian Pharmaceuticals, Inc. - Drug pipelines, Patents, Clinical ...
Jan 23, 2025 www.apexianpharma.com. Holding Company | 2005 | Indiana, United States | < 10 | www.apexianpharma.com. Last update 23 Jan 2025. Overview. Pipeline. Deal. Translational …See details»
Apexian Pharmaceuticals, Inc.:Company Profile & Technical …
Discovery Company profile page for Apexian Pharmaceuticals, Inc. including technical research,competitor monitor,market trends,company profile& stock symbolSee details»
Apexian Pharma - 2025 Company Profile - Tracxn
Mar 25, 2025 Apexian Pharma has raised a total funding of $7.73M over 9 rounds. Its first funding round was on Apr 17, 2013. Its latest funding round was a Series A round on Aug 31, …See details»
Apexian Pharmaceuticals | F6S
Apexian Pharmaceuticals - Health/Medical - Develops pharmaceuticals for cancer treatment & ocular diseases.See details»
Apexian Pharmaceuticals, Inc. | LinkedIn
Apexian Pharmaceuticals, Inc. | 8 followers on LinkedIn.See details»
ApeX Therapeutics changes name to Apexian Pharmaceuticals to …
Oct 25, 2016 ApeX Therapeutics, a clinical stage biotechnology company focused on developing novel compounds to treat cancer, today announced that it has changed its corporate name to …See details»
Apexian Pharmaceuticals | Elevate Ventures Job Board
Apexianpharma.com. Locations. Indianapolis, IN, USA. industry. Biotechnology · DeepTech · Health. Size. 1 - 10 employees. Stage. Other. founded in. 2005. Apexian Pharmaceuticals is a …See details»
Apexian Pharmaceuticals - Company Profile | ConnectFlux
About Apexian Pharmaceuticals. Apex Therapeutics is an emerging clinical-stage biotechnology company founded on the scientific discoveries of Dr. Mark R. Kelley, whose groundbreaking …See details»
Apexian Pharmaceuticals-Overview, Competitors & Contact Info
Get Apexian Pharmaceuticals’s (apexianpharma.com) location in Indiana United States, revenue, industry, competitors, technographics and contact information. Find and reach similar …See details»
Apexian Pharmaceuticals is Closing a Series A Round to ... - BioSpace
Nov 29, 2017 INDIANAPOLIS--(BUSINESS WIRE)-- Apexian Pharmaceuticals, Inc., an Indiana-based clinical stage biotechnology company developing novel compounds to treat cancer, …See details»
Apexian Pharmaceuticals Presents Data on Their Lead Drug for …
Dec 5, 2018 Apexian Pharmaceuticals is a patient-centered biotechnology company dedicated to developing novel anti-cancer compounds that target the multiple functions of the APE1 …See details»
Apexian Pharmaceuticals - PitchBook
Deal Type Date Amount Raised to Date Post-Val Status Stage; 8. Later Stage VC: 31-Aug-2021: $100K: Completed: Clinical Trials - Phase 2: 7. Later Stage VC: 20-Dec-2019See details»
Alcon Completes Acquisition of Aerie Pharmaceuticals, Inc ...
Organization: PUB. Revenues: $9.8 billion (2024) Net Income: $1.5 billion (Core) (2024) Release Summary. Alcon Completes Acquisition of Aerie Pharmaceuticals, Inc., Strengthening …See details»